Health at Scale lands $16M Series A to bring machine learning to healthcare

Health at Scale, a startup with founders who have both medical and engineering expertise, wants to bring machine learning to bear on healthcare treatment options to produce outcomes with better results and less aftercare. Today the company announced a $16 million Series A. Optum, which is part of the UnitedHealth Group, was the sole investor. Today, when people look at treatment options, they may look at a particular surgeon or hospital, or simply what the insurance company will cover, but they typically lack the data to make truly informed decisions.